Pharmanutra S.p.A.

Milan Stock Exchange:PHN.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

🛍 Retail & Wholesale

🛍 Specialty Retail

Location

Italy

Market Cap

USD 526.39 M

Share Price

USD 54.23

Avg Daily Volume

9,931

Change (1 day)

2.23%

Change (1 year)

7.80%

Change (YTD)

-4.21%

Pharmanutra S.p.A. Free Cash Flow for the year ending December 31, 2024: USD 16.83 M

Pharmanutra S.p.A. Free Cash Flow is USD 16.83 M for the year ending December 31, 2024, a -1,417.64% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Pharmanutra S.p.A. Free Cash Flow for the year ending December 31, 2023 was USD -1.28 M, a -86.27% change year over year.
Pharmanutra S.p.A. Free Cash Flow for the year ending December 31, 2022 was USD -9.30 M, a -152.95% change year over year.
Pharmanutra S.p.A. Free Cash Flow for the year ending December 31, 2021 was USD 17.56 M, a 37.40% change year over year.
Pharmanutra S.p.A. Free Cash Flow for the year ending December 31, 2020 was USD 12.78 M, a 59.95% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Free Cash Flow	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	118
Sector	🏥 Health Care
Industries Pharmaceuticals 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies 🛍 Retail & Wholesale 🛍 Specialty Retail

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.